Gufic BioSciences holds 41st AGM, approves dividend and key re-appointments

Gufic BioSciences Limited successfully conducted its 41st Annual General Meeting (AGM) on Monday, September 29, 2025, via video conferencing. chairman and managing director Mr. Jayesh P. Choksi presided over the meeting, which saw the adoption of the audited standalone and consolidated financial statements for the financial year ended March 31, 2025. A final dividend of Re. 0.10/- per equity share (10% on a face value of Re. 1/- per share) was also declared for the same period.

Key appointments included the re-appointment of Mr. Jayesh P. Choksi as a director and M/s. Mittal Agarwal & Co. as statutory auditors for a second five-year term, concluding at the 46th AGM. Additionally, shareholders ratified the remuneration for M/s. Poddar & Co. as cost auditors for the financial years 2024-25 and 2025-26. M/s. Manish Ghia and Associates were appointed as secretarial auditor of the company for a term of five consecutive years commencing from the financial year 2025-26 until the financial year 2029-30.

The meeting saw 49 shareholders in attendance via video conferencing/OAVM. All resolutions were passed without any adverse remarks from the statutory auditor's report. The AGM concluded at 04:25 p.m. IST, with e-voting results to be published on the company and stock exchange websites within two working days.